Isotretinoin

Rediff.com » News » Isotretinoin

News for Isotretinoin

Business

Sun Pharma ends patent dispute with Actavis

Sun Pharmaceutical has announced its US subsidiary, Ranbaxy Pharmaceuticals, and other partners have entered into a settlement, ending the patent litigation with drug maker Actavis over anti-acne......

Ranbaxy gets FDA nod for Isotretinoin capsules

Ranbaxy Laboratories on Monday said it has received the US Food and Drug Administration's approval to manufacture and market Isotretinoin capsules, a generic version of Hoffman LaRoche's......

Markets finish higher for 5th straight session; oil, metals shine

Smart rally in the oil and gas stocks and metal shares tracking a rebound in the overnight global commodity prices lifted sentiments. Markets closed higher for the fifth straight session on......

Dr Reddy's: New launches to drive growth

Dr Reddy’s Laboratories (DRL) has surged nearly 21% from its closing low of Rs 1,737.60 on March 01, 2013 on the back of increased traction in approvals from the US Food and Drug......

Ranbaxy recalls skin care drug from UK

Ranbaxy Ltd has been asked by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the largest drug regulator in Europe, to recall its drugs used to treat skin infections.Ranbaxy (UK)......

Rediff News

Isotretinoin

News for Isotretinoin

Sun Pharma ends patent dispute with Actavis

Ranbaxy gets FDA nod for Isotretinoin capsules

Markets finish higher for 5th straight session; oil, metals shine

Dr Reddy's: New launches to drive growth

Ranbaxy recalls skin care drug from UK

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS